173 related articles for article (PubMed ID: 10471584)
1. Mononuclear and polymorphonuclear leukocyte dispositions of clarithromycin and azithromycin in AIDS patients requiring Mycobacterium avium complex prophylaxis.
Bui KQ; McNabb J; Li C; Nightingale CH; Nicolau DP
Antimicrob Agents Chemother; 1999 Sep; 43(9):2302-4. PubMed ID: 10471584
[TBL] [Abstract][Full Text] [Related]
2. Comparison of azithromycin leukocyte disposition in healthy volunteers and volunteers with AIDS.
McNabb J; Owens RC; Xuan D; Quintiliani R; Nightingale CH; Nicolau DP
Int J Antimicrob Agents; 2000 Sep; 16(1):37-43. PubMed ID: 11185411
[TBL] [Abstract][Full Text] [Related]
3. Presence of macrolide resistance in respiratory flora of HIV-Infected patients receiving either clarithromycin or azithromycin for Mycobacterium avium complex prophylaxis.
Aberg JA; Wong MK; Flamm R; Notario GF; Jacobson MA
HIV Clin Trials; 2001; 2(6):453-9. PubMed ID: 11742432
[TBL] [Abstract][Full Text] [Related]
4. Clarithromycin prophylaxis against disseminated Mycobacterium avium complex in patients with AIDS.
Archange YR; Carrey Z; Zanlungo PG
J Int Assoc Physicians AIDS Care; 1995 Aug; 1(7):20-2. PubMed ID: 11362747
[TBL] [Abstract][Full Text] [Related]
5. Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS.
Cohn DL
Drugs; 1997; 54 Suppl 2():8-15; discussion 28-9. PubMed ID: 9358195
[TBL] [Abstract][Full Text] [Related]
6. Prophylaxis against disseminated Mycobacterium avium complex in AIDS.
Ong EL
J Infect; 1999 Jan; 38(1):6-8. PubMed ID: 10090497
[No Abstract] [Full Text] [Related]
7. Interventions for the prevention of mycobacterium avium complex in adults and children with HIV.
Uthman MM; Uthman OA; Yahaya I
Cochrane Database Syst Rev; 2013 Apr; (4):CD007191. PubMed ID: 23633339
[TBL] [Abstract][Full Text] [Related]
8. Minimum inhibitory concentrations of azithromycin in clinical isolates of
Uwamino Y; Aoki W; Inose R; Kamoshita Y; Mikita K; Namkoong H; Nishimura T; Matsushita H; Hasegawa N
Microbiol Spectr; 2024 Jun; 12(6):e0021824. PubMed ID: 38687080
[TBL] [Abstract][Full Text] [Related]
9. Azithromycin in the prophylaxis of opportunistic infections in AIDS.
McCutchan JA
Int J STD AIDS; 1996; 7 Suppl 1():34-7. PubMed ID: 8652726
[TBL] [Abstract][Full Text] [Related]
10. Antivirals key to MAC prevention regimen.
AIDS Alert; 1996 Sep; 11(9):101-3. PubMed ID: 11363722
[TBL] [Abstract][Full Text] [Related]
11. [Azithromycin and Mycobacterium avium infection].
Perronne C
Pathol Biol (Paris); 1995 Jun; 43(6):565-7. PubMed ID: 8539084
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.
Pierce M; Crampton S; Henry D; Heifets L; LaMarca A; Montecalvo M; Wormser GP; Jablonowski H; Jemsek J; Cynamon M; Yangco BG; Notario G; Craft JC
N Engl J Med; 1996 Aug; 335(6):384-91. PubMed ID: 8663871
[TBL] [Abstract][Full Text] [Related]
13. MAC prophylaxis revisited.
Torres G
GMHC Treat Issues; 1996 Apr; 10(4):6-7, 10. PubMed ID: 11363706
[TBL] [Abstract][Full Text] [Related]
14. A Rapid Screening Assay for Clarithromycin-Resistant Mycobacterium avium Complex Using Melting Curve Analysis with Nonfluorescent Labeled Probes.
Aoki A; Jinno H; Ogawa K; Nakagawa T; Inagaki T; Wajima T; Okamoto Y; Uchiya KI
Microbiol Spectr; 2023 Feb; 11(1):e0432622. PubMed ID: 36622171
[TBL] [Abstract][Full Text] [Related]
15. The role of advanced generation macrolides in the prophylaxis and treatment of Mycobacterium avium complex (MAC) infections.
Amsden GW; Peloquin CA; Berning SE
Drugs; 1997 Jul; 54(1):69-80. PubMed ID: 9211081
[TBL] [Abstract][Full Text] [Related]
16. Emergence of Mycobacterium avium populations resistant to macrolides during experimental chemotherapy.
Bermudez LE; Petrofsky M; Kolonoski P; Young LS
Antimicrob Agents Chemother; 1998 Jan; 42(1):180-3. PubMed ID: 9449283
[TBL] [Abstract][Full Text] [Related]
17. Rationale for the prevention of disseminated Mycobacterium avium-intracellulare complex disease.
Dautzenberg B
Drugs; 1997; 54 Suppl 2():1-7; discussion 28-9. PubMed ID: 9358194
[TBL] [Abstract][Full Text] [Related]
18. Peak Plasma Concentration of Azithromycin and Treatment Responses in Mycobacterium avium Complex Lung Disease.
Jeong BH; Jeon K; Park HY; Moon SM; Kim SY; Lee SY; Shin SJ; Daley CL; Koh WJ
Antimicrob Agents Chemother; 2016 Oct; 60(10):6076-83. PubMed ID: 27480854
[TBL] [Abstract][Full Text] [Related]
19. Clarithromycin prophylaxis for disseminated Mycobacterium avium complex infection--efficacy and acquired resistance.
Shafran SD
Clin Infect Dis; 1998 Oct; 27(4):813-5. PubMed ID: 9798038
[No Abstract] [Full Text] [Related]
20. A randomized, double-blind trial comparing azithromycin and clarithromycin in the treatment of disseminated Mycobacterium avium infection in patients with human immunodeficiency virus.
Dunne M; Fessel J; Kumar P; Dickenson G; Keiser P; Boulos M; Mogyros M; White AC; Cahn P; O'Connor M; Lewi D; Green S; Tilles J; Hicks C; Bissett J; Schneider MM; Benner R
Clin Infect Dis; 2000 Nov; 31(5):1245-52. PubMed ID: 11073759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
